JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the ARTIST study, an RCT evaluating ...

In this week’s Kern Cares, Dr. Patel from the California Cardiovascular Institute joined Studio 17 to highlight how modern heart treatments ...

NJBIZ spotlights under-recognized health care leaders, from startup founders to behind-the-scenes pros driving innovation.